Abstract
NRF2 mutations in patients with hepatocellular carcinoma (HCC) are associated with poor response to trans-arterial embolization (TAE). We sought to determine if CT radiomic features could predict mutation status.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
